Dendritic cell differentiation and maturation in the presence of HIV type 2 envelope.

Dendritic cells (DCs) are fundamental for the initiation of immune responses and are important players in AIDS immunopathogenesis. Impairment of DC function may result from bystander effects of HIV-1 envelope proteins independently of direct HIV-1 infection. HIV-2 envelope proteins are thought to interact with a broader range of receptors than those of HIV-1, and have been shown to have T cell immunosuppressive properties mediated by monocytes. The effects of HIV-2 envelope on DC differentiation and maturation were investigated. The modulatory properties of the HIV-2 envelope on DC generated from monocytes were assessed using both recombinant proteins (HIV-2(ROD) and HIV-2(ALI)) and whole chemically inactivated virus (aldrithiol-2-treated HIV-2(ROD)). DC phenotype was assessed by flow cytometry and DC function by their ability to stimulate allogeneic T cells and to produce cytokines. We demonstrate that HIV-2 Env had no effects upon DC differentiation and maturation despite its broad receptor usage and ability to modulate monocyte function. It is plausible to speculate that a reduced ability of the HIV-2 Env to impair myeloid DC function could represent a contributory factor to the relatively benign course of HIV-2 disease.

[1]  David A. Hume,et al.  Macrophages as APC and the Dendritic Cell Myth , 2008, The Journal of Immunology.

[2]  A. E. Sousa,et al.  Increased frequency of CD25dimCD4+ T-cells in HIV-2 infection, a naturally occurring attenuated form of HIV-1. , 2008, Clinical immunology.

[3]  M. Altfeld,et al.  Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands , 2008, AIDS.

[4]  F. Brun-Vézinet,et al.  Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France , 2008, AIDS.

[5]  A. E. Sousa,et al.  Monocyte‐mediated T cell suppression by HIV‐2 envelope proteins , 2007, European journal of immunology.

[6]  K. Akashi,et al.  The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. , 2007, Blood.

[7]  R. Steinman,et al.  The interaction of HIV with dendritic cells: outcomes and pathways , 2007, Trends in Immunology.

[8]  J. Mascola,et al.  Dendritic Cells Are Less Susceptible to Human Immunodeficiency Virus Type 2 (HIV-2) Infection than to HIV-1 Infection , 2007, Journal of Virology.

[9]  R. Cheynier,et al.  Efficient Thymopoiesis Contributes to the Maintenance of Peripheral CD4 T Cells during Chronic Human Immunodeficiency Virus Type 2 Infection , 2007, Journal of Virology.

[10]  S. Rowland-Jones,et al.  Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1? , 2007, Nature Immunology.

[11]  A. E. Sousa,et al.  Rate of Increase in Circulating IL-7 and Loss of IL-7Rα Expression Differ in HIV-1 and HIV-2 Infections: Two Lymphopenic Diseases with Similar Hyperimmune Activation but Distinct Outcomes1 , 2007, The Journal of Immunology.

[12]  A. Fauci,et al.  HIV-1 gp120 inhibits TLR9-mediated activation and IFN-α secretion in plasmacytoid dendritic cells , 2007, Proceedings of the National Academy of Sciences.

[13]  A. Cunningham,et al.  HIV Induces Maturation of Monocyte-Derived Dendritic Cells and Langerhans Cells1 , 2006, The Journal of Immunology.

[14]  C. Chougnet,et al.  Role of gp120 in dendritic cell dysfunction in HIV infection , 2006, Journal of leukocyte biology.

[15]  Miguel García,et al.  Increased Frequency of Circulating CCR5+ CD4+ T Cells in Human Immunodeficiency Virus Type 2 Infection , 2006, Journal of Virology.

[16]  R. Koup,et al.  PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection , 2006, The Journal of experimental medicine.

[17]  Philip J. R. Goulder,et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.

[18]  R. Balderas,et al.  Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction , 2006, Nature Medicine.

[19]  John P. Moore,et al.  HIV-1 Envelope Triggers Polyclonal Ig Class Switch Recombination through a CD40-Independent Mechanism Involving BAFF and C-Type Lectin Receptors1 , 2006, The Journal of Immunology.

[20]  J. Lifson,et al.  Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions. , 2006, Blood.

[21]  J. Mascola,et al.  Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells , 2005, The Journal of experimental medicine.

[22]  J. Moniz-Pereira,et al.  HIV-2 infection and chemokine receptors usage - clues to reduced virulence of HIV-2. , 2005, Current HIV research.

[23]  F. Belardelli,et al.  Human Immunodeficiency Virus Type 1 gp120 Induces Abnormal Maturation and Functional Alterations of Dendritic Cells: a Novel Mechanism for AIDS Pathogenesis , 2004, Journal of Virology.

[24]  J. Lifson,et al.  Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells , 2004, Journal of Virology.

[25]  B. Freedman,et al.  Macrophage activation through CCR5‐ and CXCR4‐mediated gp120‐elicited signaling pathways , 2003, Journal of leukocyte biology.

[26]  C. Hung,et al.  Differential impact of late-stage HIV-1 infection on in vitro and in vivo maturation of myeloid dendritic cells. , 2003, Journal of acquired immune deficiency syndromes.

[27]  B. Gazzard,et al.  Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. , 2003, Blood.

[28]  R. Maserati,et al.  B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. , 2003, Blood.

[29]  S. Spector,et al.  HIV-1 gp120 modulates the immunological function and expression of accessory and co-stimulatory molecules of monocyte-derived dendritic cells. , 2002, Journal of hematotherapy & stem cell research.

[30]  Martin Meier-Schellersheim,et al.  CD4 T Cell Depletion Is Linked Directly to Immune Activation in the Pathogenesis of HIV-1 and HIV-2 but Only Indirectly to the Viral Load1 , 2002, The Journal of Immunology.

[31]  Z. Grossman,et al.  CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause? , 2002, Nature Medicine.

[32]  J. Lifson,et al.  Infectious and Whole Inactivated Simian Immunodeficiency Viruses Interact Similarly with Primate Dendritic Cells (DCs): Differential Intracellular Fate of Virions in Mature and Immature DCs , 2002, Journal of Virology.

[33]  L Meyer,et al.  Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. , 2001, Blood.

[34]  A. E. Sousa,et al.  Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicity , 2000, AIDS.

[35]  Q. Sattentau,et al.  Inactivation of Human Immunodeficiency Virus Type 1 Infectivity with Preservation of Conformational and Functional Integrity of Virion Surface Proteins , 1998, Journal of Virology.

[36]  H. Whittle,et al.  A Broad Range of Chemokine Receptors Are Used by Primary Isolates of Human Immunodeficiency Virus Type 2 as Coreceptors with CD4 , 1998, Journal of Virology.

[37]  H. Whittle,et al.  Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[38]  H. Nakauchi,et al.  Human immunodeficiency virus type 2 envelope glycoprotein binds to CD8 as well as to CD4 molecules on human T cells , 1997, Journal of virology.

[39]  H. Hashimoto,et al.  The production of &bgr;‐chemokines induced by HIV‐2 envelope glycoprotein , 1997, AIDS.

[40]  M. Melbye,et al.  9-year HIV-2-associated mortality in an urban community in Bissau, west Africa , 1997, The Lancet.

[41]  I. Thior,et al.  Reduced rate of disease development after HIV-2 infection as compared to HIV-1. , 1994, Science.

[42]  N. Taveira,et al.  Molecular characterization of the env gene from a non-syncytium-inducing HIV-2 isolate (HIV-2ALI) , 1994, AIDS research and human retroviruses.

[43]  J. Albert,et al.  Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. , 1993, Virology.